BLS Capital Q1 2026: $2.9B Danish Quality Compounder Book

BLS Capital Fondsmaeglerselskab A/S is one of Denmark's larger independent equity-investment firms. The firm runs concentrated global-equity strategies with explicit value-and-quality factor tilts and a stated preference for durable-moat compounders. The Q1 2026 Form 13F-HR reports $2.94 billion in US-listed equity holdings concentrated in 10 dominant positions: Yum China (YUMC) at 18.88% portfolio, S&P Global (SPGI) at 12.75%, Otis Worldwide (OTIS) at 11.51%, AutoZone (AZO) at 10.08%, Automatic Data Processing (ADP) at 8.15%, Zoetis (ZTS) at 7.87%, Moody's (MCO) at 7.70%, Mastercard (MA) at 7.63%, Visa (V) at 6.07%, Arthur J. Gallagher (AJG) at 4.77%. Top 10 concentration: 95.41% of AUM. The book is structurally a Scandinavian quality-compounder expression at scale.

BLS Capital's mandate emphasizes companies with durable competitive moats, high-margin operating economics, recurring-revenue characteristics, capital-light growth, and management capital-allocation discipline. The 13F shape reflects systematic application of these criteria across global equity universe — note that several positions are non-US-domiciled companies (YUMC is China-focused; OTIS is global elevator-and-escalator).

The book at a glance

$2.94 billion total AUM. ~10-20 meaningful positions. WhaleScore 79.00. Top 10 concentration: 95.41% — essentially the entire book.

The top 10 in detail

• Yum China (YUMC) at 18.88% — KFC, Pizza Hut, Taco Bell China operator. The Chinese quick-service-restaurant franchise. BLS Capital's largest position.
• S&P Global (SPGI) at 12.75% — Credit ratings, market intelligence, indices. Two-sided network economics, regulatory-protected pricing power.
• Otis Worldwide (OTIS) at 11.51% — Elevators and escalators globally. Service-revenue compounder (60%+ of revenue from maintenance contracts).
• AutoZone (AZO) at 10.08% — Aftermarket auto parts retail. Buyback machine plus pricing power on parts replacement.
• Automatic Data Processing (ADP) at 8.15% — Payroll and HR services. Recurring-revenue platform with regulatory moat.
• Zoetis (ZTS) at 7.87% — Animal health pharmaceuticals. Premium pricing on companion-animal and livestock products.
• Moody's (MCO) at 7.70% — Credit ratings duopoly with S&P.
• Mastercard (MA) at 7.63% — Payments network.
• Visa (V) at 6.07% — Payments network.
• Arthur J. Gallagher (AJG) at 4.77% — Insurance brokerage. M&A-driven compounder with capital-light economics.

Combined Mastercard + Visa + S&P Global + Moody's exposure: 34.15% of portfolio in financial-services data and payments infrastructure. The cluster reflects BLS Capital's view that information-and-transaction infrastructure provides durable compounding economics.

What's deliberately absent

The exclusions are striking:

1. Zero Magnificent 7 mega-cap tech. NVDA, AAPL, MSFT, AMZN, GOOGL, META, TSLA — all absent. The Magnificent 7 fails BLS Capital's value-and-quality screens at current multiples.
2. Zero energy or commodity positions. XOM, CVX, COP, COG, etc. — absent.
3. Zero pharma or biotech. JNJ, LLY, PFE, MRK — absent. Animal-health Zoetis is the closest sector exposure.
4. Zero defense or industrial heavy machinery beyond Otis. No CAT, DE, LMT, RTX.

BLS Capital's book is structurally a quality-compounder concentration — financial-and-information services platforms plus consumer-services compounders plus selective industrial services exposure. The non-participation in the major US sectors (mega-cap tech, energy, healthcare pharma, defense) is a deliberate philosophical choice.

The top 10 vs the rest

95.41% of AUM in 10 positions. The remaining 4.59% spans a handful of smaller positions. The structure is concentrated-active by design — BLS Capital does not run diversified equity allocations beyond its high-conviction selections.

What this 13F tells institutional readers

1. Quality-compounder concentration is the thesis. Every top-10 position fits the durable-moat, high-margin, capital-light, recurring-revenue framework. The structural pattern is explicit factor expression.
2. YUMC at 18.88% is the China-specific bet. Yum China is the largest exposure to Chinese consumer-discretionary spending at this concentration. The position represents BLS Capital's view that Chinese QSR franchise growth continues despite broader China-equity multiple compression.
3. The non-participation in mega-cap tech is deliberate. BLS Capital screens out names trading at multiples too high for quality-and-value factor frameworks. The Magnificent 7 absence is philosophical, not accidental.

AUM trajectory

BLS Capital's reported US 13F AUM has scaled through 2024-2026 as the firm's global-equity strategies attracted European institutional inflows. The 10-position concentration has been stable; BLS is not letting AUM growth force position-count drift.

What to track

1. Yum China Q1 2026 earnings. Chinese consumer-discretionary trajectory and KFC/Pizza Hut China unit-growth determine the largest BLS position outcome.
2. BLS Capital's Q2 2026 13F (due August 14, 2026). Watch whether top-10 positions hold or shift. Track via the institutional signals feed.
3. Payments-network regulation. Combined V + MA + SPGI + MCO at 34.15% portfolio means any Credit Card Competition Act passage or credit-ratings regulation directly affects the book.

BLS Capital's Q1 2026 13F is one of the cleanest Scandinavian quality-compounder concentrated books at scale in the US 13F universe. For more on identifying quality-discipline 13F shapes, see our payments duopoly decoder.

Source: SEC Form 13F-HR filed by BLS Capital Fondsmaeglerselskab A/S (CIK 0001670104) for the period ending 2026-03-31; available via EDGAR — BLS Capital filer index.